Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

Change Font Size

HHS Agencies’ Annual Accounting of Drug-Control Funds – Mandatory Review

The Office of National Drug Control Policy Circular requires that agencies expending funds on National Drug Control Program activities submit an annual accounting of the expenditure of such funds (21 U.S.C. § 1704). The policy also requires that an agency submit with its annual accounting an authentication by the agency’s OIG that expresses a conclusion on the reliability of the agency’s assertions. We will review HHS agencies’ compliance with the circular. We will also submit the authentication with respect to HHS’s FY 2016 annual accounting.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
Nov-16 Other HHS Agencies’ Annual Accounting of Drug-Control Funds – Mandatory Review Office of Audit Services W-00-17-52312; various reviews 2017

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201